Skip to main content
Unchecking box will stop auto data updates
Delayed Price USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 0.8700
Day High 0.9100
Open:0.8700
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Marina Biotech, Inc., formerly known as MDRNA, Inc., is a biotechnology company, focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The Company's pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs in hepatocellular carcinoma and bladder cancer. Marina's goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Marina Biotech, Inc. is headquartered in Bothell, Washington.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Marina Biotech Appoints Robert Moscato to Chief Executive Officer
GlobeNewswire - Wed Jun 20, 10:30AM CDT
GlobeNewswire - CMTX
Wed Jun 20, 10:30AM CDT
Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis, pain and oncology, today announced that its Board of Directors has appointed Robert C. Moscato, Jr. to serve as Chief Executive Officer of the Company.
CohBar Announces the Appointment of Dr. Philippe Calais to its Board
GlobeNewswire - Thu Jun 7, 7:59AM CDT
GlobeNewswire - CMTX
Thu Jun 7, 7:59AM CDT
CohBar, Inc. (NASDAQ:CWBR) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced the appointment of Philippe P. Calais, Ph.D., to its Board of Directors, and to the Board's Audit Committee.
Marina Biotech Announces a New Publication on Prestalia(R)
GlobeNewswire - Tue Feb 27, 9:14AM CST
GlobeNewswire - CMTX
Tue Feb 27, 9:14AM CST
Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis, pain and oncology, announced today further progress with its FDA-Approved Prestalia(R) hypertension drug, with the issuance of a new and independent publication on Prestalia(R): Elliott WJ and Bistrika EA (2018) Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. Expert Opin Drug Saf. 17:207-216.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.6500 +40.00% increase
on 06/15/18
Period Open:0.8600
Price movement based on the high, low and last over the given period.
0.9200 -1.09% decrease
on 06/21/18
+0.0500 (+5.81%) increase
since 05/21/18
3-Month 0.6500 +40.00% increase
on 06/15/18
Period Open:1.5000
Price movement based on the high, low and last over the given period.
1.6000 -43.13% decrease
on 03/27/18
-0.5900 (-39.33%) decrease
since 03/22/18
52-Week 0.6500 +40.00% increase
on 06/15/18
Period Open:3.8000
Price movement based on the high, low and last over the given period.
5.0000 -81.80% decrease
on 08/04/17
-2.8900 (-76.05%) decrease
since 06/22/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement